Simcere Pharmaceutical Group (SCR)
Add to Watchlists Create an AlertSimcere Pharmaceutical Group Total Expenses Quarterly
Simcere Pharmaceutical Group Total Expenses Quarterly Chart
View Total Expenses Quarterly for SCR.
Start Your YCharts Pro Platinum Membership.
Simcere Pharmaceutical Group Historical Total Expenses Quarterly Data
Pro Data ExportThere is no data for the selected date range.
About Expenses
A company's expenses are how much a company is spending before its net income. This is a useful metric to compare a company spending habits over time. Starting from the income statement, a company may have a considerable amount of revenues. As an investor goes down the Income Statement, gradually line items such as
Cost of Goods Sold,
Research and Development,
Selling, General & Admin,
Depreciation,
and other Expenses
will be subtracted from Revenues. After the aforementioned expenses have been subtracted, we are now at EBIT.
Interest,
Taxes
will be subtracted from EBIT to achieve Net Income. As you can see, there are quite a lot of expenses that are subtracted from a company's revenues before it achieves net income. We've summed the expenses for you to better understand how much a company is spending from its revenues before it hits net income, "the bottom line".
Bear in mind, increasing expenses are not a bad thing at all! If a company's revenues are increasing, there is an almost certain likelihood that expenses are increasing (Think of the phrase "it takes money to make money"). These costs are attributable to selling costs, or just the costs of the goods sold of a manufacturer. A car company might report additional revenues of a car for $30,000, but it will still cost them $15,000 to make! Situations where revenues are not increasing, but expenses are increasing rapidly can be a red flag of potential issues at a company. This metric is often used to compare a specific company over time to see the size of expenses grow quarter by quarter or year by year. Using expenses to compare against competitors can be tricky and not as useful)
This can also be referred to as "total expenses"
Learn More
View Total Expenses Quarterly for SCR.
Start Your YCharts Pro Platinum Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $199/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Platinum Member? Sign in here.
SCR Total Expenses Quarterly Benchmarks
| Companies | |
|---|---|
| Bristol-Myers Squibb | Go Pro |
| Merck | Go Pro |
| Sagent Pharmaceuticals | Go Pro |
SCR Total Expenses Quarterly Rankings
| Overall |
72nd percentile 2239 of 8006 |
| Sector |
77th percentile 156 of 686 in Healthcare |
| Industry |
77th percentile 15 of 68 in Drug Manufacturers - Specialty & Generic |
SCR Total Expenses Quarterly Range, Past 5 Years
| Minimum | Go Pro | Jun 2008 |
| Maximum | Go Pro | Dec 2012 |
| Average | Go Pro |